South San Francisco, CA · Founded 2023 · Privately Held (backing)
Developer of a bispecific antibody therapeutics platform designed for addressing immunology and inflammation. Dualitas Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $87 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $65 million across 1 recorded round; the latest was a $32.6 million early-stage round in Jul 2025.
PMV mark · valuation
$87.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$65.0M
Last round
Early Stage VC
Jul 2025
Cap table — not yet on record
Dualitas Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dualitas Therapeutics with a free account
·Watch Dualitas Therapeutics: the Monday email on marks, rounds and moves
Where does Dualitas Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Dualitas Therapeutics's 1 recorded funding rounds.
